Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1115 | 992 | 1115 | 1131 | 1471 | 2016 |
Fund Return | 11.54% | -0.76% | 11.54% | 4.19% | 8.03% | 7.26% |
Place in category | 142 | 239 | 142 | 48 | 66 | 127 |
% in Category | 11 | 23 | 11 | 5 | 12 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Equity World Technology Classic Cae | 5.12B | 27.71 | 8.73 | 18.62 | ||
Equity World Technology Classic Dis | 5.12B | 27.71 | 8.73 | 18.62 | ||
Equity World Technology I Capitalis | 5.12B | 29.01 | 9.84 | 19.83 | ||
Equity World Technology Privilege e | 5.12B | 28.87 | 9.71 | 19.64 | ||
Equity World Technology Privilege D | 5.12B | 28.87 | 9.71 | 19.64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund C2e | 13.1B | 0.67 | -1.67 | 5.66 | ||
World Healthscience Fund D2e | 1.26B | 2.71 | 0.32 | 7.80 | ||
World Healthscience Fund A2e | 13.1B | 1.94 | -0.42 | 6.99 | ||
LU1960219571 | 13.1B | 2.96 | 0.56 | - | ||
World Healthscience Fund E2e | 13.1B | 1.43 | -0.92 | 6.46 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 8.65 | 532.51 | +0.52% | |
AstraZeneca | GB0009895292 | 6.56 | 11,050.0 | +0.04% | |
Eli Lilly | US5324571083 | 6.33 | 785.41 | +2.45% | |
Sanofi | FR0000120578 | 5.04 | 100.16 | +0.27% | |
Boston Scientific | US1011371077 | 4.77 | 101.94 | +0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review